×
About 6,620 results

ALLMedicine™ Diabetic Ketoacidosis Center

Research & Reviews  1,715 results

Use of SGLT-2 Inhibitors to Treat Chronic Kidney Disease in Primary Care.
https://doi.org/10.12788/jfp.0389
The Journal of Family Practice; Bakris G

Aug 13th, 2022 - Chronic kidney disease (CKD) remains underrecognized by patients and clinicians in the primary care setting, largely due to its asymptomatic presentation in early stages. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have demonstrated kidney-...

Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A ca...
https://doi.org/10.1111/jcpt.13737
Journal of Clinical Pharmacy and Therapeutics; Han J, Xie S et. al.

Aug 12th, 2022 - Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report.|2022|Han J,Xie S,Jiao H,|

Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597...
https://doi.org/10.1038/s41390-022-02241-2
Pediatric Research; Elgenidy A, Awad AK et. al.

Aug 12th, 2022 - Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of type 1 diabetes mellitus (T1DM) that has increased during the COVID-19 pandemic. This study will not only shed light on such life-threatening complications but also be a...

Healthcare Use Prior to Diabetes Diagnosis in Children Before and During COVID.
https://doi.org/10.1542/peds.2022-058349
Pediatrics Shulman R, Nakhla M et. al.

Aug 11th, 2022 - During COVID-19, healthcare systems reorganized with less ambulatory care and a shift to virtual care (1). There was an increase in diabetic ketoacidosis (DKA), a preventable, life-threatening condition, at diabetes onset in children during COVID-...

Management of hospitalized patients with mild to moderate diabetic ketoacidosis using a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351868
Medicine Yoo MS, Daniels A et. al.

Aug 11th, 2022 - Although the practice of using rapid-acting subcutaneous insulin for the management of mild-to-moderate diabetic ketoacidosis is becoming increasingly popular, the continuous insulin infusion remains widely utilized, and its real-world applicabili...

see more →

Guidelines  6 results

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904174/
Diabetes & Metabolism; Sasaki H, Itoh A et. al.

Jul 3rd, 2022 - To the Editor We read with great interest the article “Fulminant type 1 diabetes (T1DM) after Covid-19 vaccination” by Tang et al. in this journal [1]. The authors examined islet autoantibodies, HLA alleles, and the capacity for insulin secreti...

ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID...
https://doi.org/10.1111/pedi.13118
Pediatric Diabetes; Priyambada L, Wolfsdorf JI et. al.

Sep 17th, 2020 - The International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guideline 2018 for management of diabetic ketoacidosis (DKA) and the hyperglycemic hyperosmolar state provide comprehensive guidance for management of DKA ...

Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diab...
https://doi.org/10.1016/j.numecd.2020.06.006
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Lapolla A, Amaro F et. al.

Aug 11th, 2020 - Diabetic ketoacidosis (DKA) is a serious medical emergency once considered typical of type 1 diabetes (T1DM), but now reported to occur in type 2 and GDM patients as well. DKA can cause severe complications and even prove fatal. The aim of our stu...

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 28th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

Dying well with diabetes.
https://doi.org/10.21037/apm.2018.12.10
Annals of Palliative Medicine; James J

Jan 30th, 2019 - Death is an inevitable part of living. There are undoubtedly clinical and psychological challenges when any individual is passing from life to death. For a person with a long-term condition such as diabetes, these challenges can be compounded and ...

see more →

Drugs  394 results see all →

Clinicaltrials.gov  114 results

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treat...
https://clinicaltrials.gov/ct2/show/NCT02864914

Aug 3rd, 2022 - Empagliflozin (Jardiance), a highly potent and selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2), was approved in Europe in May 2014 for the treatment of type 2 diabetes mellitus (T2DM) to improve glycaemic control in adults. As pa...

The Effect of Serious Game Developed for Nursing Students
https://clinicaltrials.gov/ct2/show/NCT05321303

Aug 3rd, 2022 - This study aims to answer the following problematic: How to improve the learning of satisfaction and self-confidence, knowledge Levels, problem-solving, critical thinking skills in serious game, and standardized patients practice for students. Thi...

The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies
https://clinicaltrials.gov/ct2/show/NCT05145049

Jul 22nd, 2022 - Lactate level is one of the easy-to-measure parameters that are frequently used in anesthesia and intensive care clinical practice, especially to evaluate the severity of disease and the response to treatment. In patients with high lactate levels,...

Identifying Risk Factors for Developing AKI in Sepsis
https://clinicaltrials.gov/ct2/show/NCT04825639

Jul 22nd, 2022 - It is a descriptive study to report the prevalence ofAcute Kidney Injury ( AKI) in the two cohorts of sepsis and Diabetic Ketoacidosis ( DKA). In addition we aim to evaluate the relation with hyperchloremia. In both groups, attempts will be made t...

Neurocognitive Performance During Hyperglycemia , and Brain Tissue Integrity in Youth With Type 1 Diabetes and in Healthy
https://clinicaltrials.gov/ct2/show/NCT02923323

Jul 13th, 2022 - An inter-disciplinary repeated measures case control design study is proposed, whereby novel methods of brain imaging, brain electrophysiological activity, neuropsychological tests will be examined in concert with the children's dynamic changes in...

see more →

News  416 results

Extreme Temperatures Can Reduce the Efficacy of Drug Therapy
https://www.medscape.com/viewarticle/979037

Aug 10th, 2022 - High temperatures can reduce the efficacy and safety of drug therapy. Alina Hermann, MD, and her team from Heidelberg University Hospital in Germany explain how heat can affect the quality of pharmacotherapy, and they clarify where special attenti...

Euthyroid Sick Syndrome Hits Many With Diabetic Ketosis 
https://www.medscape.com/viewarticle/978764

Aug 5th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways The results showed a 58% prevalence of euthyroid sick syndrome (ESS) in 396 adults hospitalized with diabet...

Chest pain and difficulty swallowing
https://www.mdedge.com/familymedicine/article/256263/dermatology/chest-pain-and-difficulty-swallowing
MDedge Family Medicine;

Jul 14th, 2022 - The posteroanterior (PA) and lateral view CXRs, as well as the CT scan, revealed the presence of retrosternal air and confirmed the patient’s diagnosis of pneumomediastinum. Pneumomediastinum—the presence of free air in the mediastinum—can develop.

Childhood Type 1 Diabetes Tests Suggested at Ages 2 and 6
https://www.medscape.com/viewarticle/976992

Jul 12th, 2022 - Screening children for type 1 diabetes-associated islet autoantibodies at ages 2 years and 6 years would identify most of those who go on to develop the condition by mid-adolescence, new data suggest. Both genetic screening and islet-cell autoanti...

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904174/
Diabetes & Metabolism; Sasaki H, Itoh A et. al.

Jul 3rd, 2022 - To the Editor We read with great interest the article “Fulminant type 1 diabetes (T1DM) after Covid-19 vaccination” by Tang et al. in this journal [1]. The authors examined islet autoantibodies, HLA alleles, and the capacity for insulin secreti...

see more →

Patient Education  3 results see all →